Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets K Schulze, S Imbeaud, E Letouzé, LB Alexandrov, J Calderaro, ... Nature genetics 47 (5), 505-511, 2015 | 1647 | 2015 |
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma C Guichard, G Amaddeo, S Imbeaud, Y Ladeiro, L Pelletier, IB Maad, ... Nature genetics 44 (6), 694-698, 2012 | 1542 | 2012 |
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma C Guichard, G Amaddeo, S Imbeaud, Y Ladeiro, L Pelletier, IB Maad, ... Nature genetics 44 (6), 694-698, 2012 | 1542 | 2012 |
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations Y Ladeiro, G Couchy, C Balabaud, P Bioulac‐Sage, L Pelletier, ... Hepatology 47 (6), 1955-1963, 2008 | 858 | 2008 |
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry P Bioulac‐Sage, S Rebouissou, C Thomas, JF Blanc, J Saric, A Sa Cunha, ... Hepatology 46 (3), 740-748, 2007 | 630 | 2007 |
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification J Calderaro, G Couchy, S Imbeaud, G Amaddeo, E Letouzé, JF Blanc, ... Journal of hepatology 67 (4), 727-738, 2017 | 594 | 2017 |
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours S Rebouissou, M Amessou, G Couchy, K Poussin, S Imbeaud, C Pilati, ... Nature 457 (7226), 200-204, 2009 | 531 | 2009 |
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas JC Nault, S Datta, S Imbeaud, A Franconi, M Mallet, G Couchy, E Letouzé, ... Nature genetics 47 (10), 1187-1193, 2015 | 499 | 2015 |
Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience P Bioulac‐Sage, H Laumonier, G Couchy, B Le Bail, A Sa Cunha, ... Hepatology 50 (2), 481-489, 2009 | 486 | 2009 |
Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation JC Nault, G Couchy, C Balabaud, G Morcrette, S Caruso, JF Blanc, ... Gastroenterology 152 (4), 880-894. e6, 2017 | 365 | 2017 |
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection JC Nault, A De Reyniès, A Villanueva, J Calderaro, S Rebouissou, ... Gastroenterology 145 (1), 176-187, 2013 | 346 | 2013 |
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas C Pilati, M Amessou, MP Bihl, C Balabaud, JT Van Nhieu, V Paradis, ... Journal of Experimental Medicine 208 (7), 1359-1366, 2011 | 272 | 2011 |
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas C Pilati, M Amessou, MP Bihl, C Balabaud, JT Van Nhieu, V Paradis, ... Journal of Experimental Medicine 208 (7), 1359-1366, 2011 | 272 | 2011 |
Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation C Pilati, E Letouzé, JC Nault, S Imbeaud, A Boulai, J Calderaro, ... Cancer cell 25 (4), 428-441, 2014 | 269 | 2014 |
Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting B Beuselinck, S Job, E Becht, A Karadimou, V Verkarre, G Couchy, ... Clinical cancer research 21 (6), 1329-1339, 2015 | 268 | 2015 |
Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression S Rebouissou, A Franconi, J Calderaro, E Letouzé, S Imbeaud, C Pilati, ... Hepatology 64 (6), 2047-2061, 2016 | 256 | 2016 |
Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis E Letouzé, J Shinde, V Renault, G Couchy, JF Blanc, E Tubacher, ... Nature communications 8 (1), 1315, 2017 | 250 | 2017 |
Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma JC Nault, Y Martin, S Caruso, TZ Hirsch, Q Bayard, J Calderaro, C Charpy, ... Hepatology 71 (1), 164-182, 2020 | 156 | 2020 |
Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response S Caruso, AL Calatayud, J Pilet, T La Bella, S Rekik, S Imbeaud, ... Gastroenterology 157 (3), 760-776, 2019 | 155 | 2019 |
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress Q Bayard, L Meunier, C Peneau, V Renault, J Shinde, JC Nault, I Mami, ... Nature Communications 9 (1), 5235, 2018 | 146 | 2018 |